RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis by Rui Han, Hongxing Yang, Lingeng Lu, Lizhu Lin

Get full text

Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis by Rui Han, Hongxing Yang, Lingeng Lu, Lizhu Lin

Get full text

The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases by Lizhu Lin, Jiemei Chu, Sanqi An, Xinli Liu, Runxian Tan

Get full text

Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants by Xiangjun Qi, Shujing Wang, Caishan Fang, Jie Jia, Lizhu Lin, Tianhui Yuan

Get full text

Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial. by Jiaming Wu, Yu Dong, Wanshan Zhu, Jincheng Meng, Huatang Zhang, Cantu Fang, Lizhu Lin

Get full text

Clinical Efficacy of Hexue Tongbi Formula on Oxaliplatin-Induced Peripheral Neuropathy: A Randomized Controlled Study by Lingling Sun MD, Yiying Lv MM, Duo Li MM, Jingyu Feng MD, Zhuangzhong Chen MM, Lizhu Lin MD

Get full text

Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model by Hanhan Li, Shan Liu, Shang Xiang, Wei Guo, Jiayang Huang, Ling Yu, Zhuangzhong Chen, Yuan lin, Lizhu Lin, Hanrui Chen

Get full text

External Application of a Xiaozhen zhiyang Decoction for Facial Rash Related to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Chinese Patients: A Prospective Singl... by Jietao Lin MD, Lingling Sun MD, Jing Zhang MM, Ke Zhu MD, Hanrui Chen MD, Xinting Zhen MD, Yang Cao MD, Siyu Wang MD, Lizhu Lin MD

Get full text

A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagy by Jue Zhang, Zhipeng Qu, Xi Xiao, David L. Adelson, Funeng Wang, Aisheng Wei, Yuka Harata-Lee, Jian Cui, Dongying He, Le Xie, Lingling Sun, Jing Li, Zijing Huang, Thazin Aung, Hong Yao, Lizhu Lin

Get full text

Guidelines for the clinical application of the Xihuang pill for the prevention and treatment of breast hyperplasia diseases by Hongmei Tang, Qin Lu, Shiyin Feng, Zhiwei Xiao, Wanyin Wu, Gaofeng Chen, Li Deng, Tianqi Yu, Junyan Wu, Hua Lin, Bo Ji, Jietao Lin, Chengguang Zhang, Liming Li, Tao Liu, Yong Ouyang, Kaijun Lei, Jun Chen, Weiwen Peng, Zhenwen Qiu, Qingqun Cai, Qi Liang, Cuiling Liu, Yuzhen Li, Lixia Zhu, Zexin Zhang, Xueting Liu, Lizhu Lin, Zhihua Zheng

Get full text

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study by Jian Zhang, Ping Lu, Hui Zhao, Jianhua Chen, Wei Shi, Xiubao Ren, Yi Hu, Liping Wang, Hongmei Zhang, Chengchu Zhu, Jianping Xiong, Jianying Zhou, Jun Zhao, Yongqian Shu, Caicun Zhou, Xiaorong Dong, Yunpeng Liu, Yunchao Huang, Jian Zhao, Yiping Zhang, Sheng Hu, Xiaoyan Lin, Yueyin Pan, Jiuwei Cui, Lizhu Lin, Kangsheng Gu, Yun Fan, Qun Chen, Gongyan Chen, Zhehai Wang, Fengying Wu, Guangyu An, Shuliang Guo, Xiaodong Jiang, Yongsheng Wang, Jifeng Feng, Jianhua Shi, QiMing Wang, Jianan Huang, Lejie Cao, Jianhua Chang, Zhiyong He, Jian Fang, Faguang Jin, Hongjun Gao, Cuimin Ding, Xiangdong Zhou, Anwen Liu, Jianjin Huang, Beili Gao, Yinglan Chen, Chengping Hu, Zhigao Wang, Xinjing Ma

Get full text